Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES is an Endocrine Nurse Practitioner and Program Director of Technology at University Hospitals and Faculty Advisor for Close Concerns. Dr. Bellini earned her Bachelor's degree in Nursing from Drexel University and Family Nurse Practitioner and Doctor of Nursing Practice from D'Youville University. Dr. Bellini holds board certifications as a family nurse practitioner and in advanced diabetes management. She has published studies on topics including the use of GLP-1 agonists in patients with type 1 diabetes and using technology in diabetes management. She has been a speaker nationally and internationally regarding diabetes management and the impact of technology on diabetes care and outcomes.
As a faculty member for Close Concerns, Dr. Bellini works with the associates to bring perspective as a patient and a clinician to data and outcomes presented at conferences and earnings reports. She co-hosts podcast Diabetes Dialogue: Technology, Therapeutics, & Real Word Perspectives with colleague Dr. Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES.
UH Westshore Primary Care
26908 Detroit Rd
Westlake, OH 44145
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood, OH 44122
Landerbrook II HC Ste 100 Monarch
5885 Landerbrook Dr
Suite: 100 Monarch
Mayfield Heights, OH 44124
Certifications & Memberships
- NP - Family - American Nurses Credentialing Center
D'youville College (2021)
D'youville College (2018)
Drexel University (2014)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Natalie Bellini did not disclose any Outside Relationships with Industry.